VolitionRX Ltd. (VNRX) - Product Pipeline Analysis, 2016 Update

Report code: GDME321317PD

Publisher: GlobalData

Formats: PDF

Published: July 05, 2016

Number of pages: 69

VolitionRX Ltd. (VolitionRX) is a life science company that develops diagnostic solutions. The company develops blood-based diagnostic tests for detecting and diagnosing cancer and other diseases. It provides ELISA diagnostic technology with nucleosome detection and analysis techniques. VolitionRX develops tests on the basis of Nucleosomics biomarker platform, designed to identify and measure nucleosomes in the bloodstream or other bodily fluid. The company has developed epigenetic NuQ assays to detect cancer by detecting nucleosomes containing specific nucleotides, modified histones, specific histone variants, nucleosome-protein adducts and total blood nucleosome levels. The company has its presence in Belgium. VolitionRX is headquartered in Singapore.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company VolitionRX Ltd.

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reason To Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 7

VolitionRX Ltd. Company Snapshot 8

VolitionRX Ltd. Company Overview 8

VolitionRX Ltd. Pipeline Products and Clinical Trials Overview 9

VolitionRX Ltd. – Pipeline Analysis Overview 11

Key Facts 11

VolitionRX Ltd. - Major Products and Services 12

VolitionRX Ltd. Pipeline Products by Development Stage 13

VolitionRX Ltd. Clinical Trials by Trial Status 17

VolitionRX Ltd. Pipeline Products Overview 19

Colorectal Cancer Panel Test 19

Colorectal Cancer Panel Test Product Overview 19

HyperGenomics Diagnostic Test - Colon Cancer 20

HyperGenomics Diagnostic Test - Colon Cancer Product Overview 20

HyperGenomics Diagnostic Test - Leukaemia 21

HyperGenomics Diagnostic Test - Leukaemia Product Overview 21

HyperGenomics Diagnostic Test - Prostate Cancer 22

HyperGenomics Diagnostic Test - Prostate Cancer Product Overview 22

NuQ - A Androgen Receptor Cell Culture ELISA Kit 23

NuQ - A Androgen Receptor Cell Culture ELISA Kit Product Overview 23

NuQ - A EZH2 Cell Culture ELISA Kit 24

NuQ - A EZH2 Cell Culture ELISA Kit Product Overview 24

NuQ - A HMGB1 Cell Culture ELISA Kit 25

NuQ - A HMGB1 Cell Culture ELISA Kit Product Overview 25

NuQ - A Oestrogen Receptor Cell Culture ELISA Kit 26

NuQ - A Oestrogen Receptor Cell Culture ELISA Kit Product Overview 26

NuQ - A Progesterone Receptor Cell Culture ELISA Kit 27

NuQ - A Progesterone Receptor Cell Culture ELISA Kit Product Overview 27

NuQ - Prostate Cancer 28

NuQ - Prostate Cancer Product Overview 28

NuQ - Prostate Cancer Clinical Trial 29

NuQ - T 30

NuQ - T Product Overview 30

NuQ Diagnostic Test - Lung Cancer 31

NuQ Diagnostic Test - Lung Cancer Product Overview 31

NuQ Diagnostic Test - Lung Cancer Clinical Trial 32

NuQ Diagnostic Test - Pancreatic Cancer 33

NuQ Diagnostic Test - Pancreatic Cancer Product Overview 33

NuQ Diagnostic Test - Pancreatic Cancer Clinical Trial 34

NuQ Endo 35

NuQ Endo Product Overview 35

NuQ T003 Assay - Colorectal Cancer 36

NuQ T003 Assay - Colorectal Cancer Product Overview 36

NuQ V001 Assay - Colorectal Cancer 37

NuQ V001 Assay - Colorectal Cancer Product Overview 37

NuQ X001S Assay - Colorectal Cancer 38

NuQ X001S Assay - Colorectal Cancer Product Overview 38

NuQ X001S Assay - Colorectal Cancer Clinical Trial 39

NuQ-B 40

NuQ-B Product Overview 40

NuQ-IHC 41

NuQ-IHC Product Overview 41

NuQ-M Gamma - H2AX Cell Culture ELISA Kit 42

NuQ-M Gamma - H2AX Cell Culture ELISA Kit Product Overview 42

NuQ-M H3K27(Me)3 Cell Culture ELISA Kit 43

NuQ-M H3K27(Me)3 Cell Culture ELISA Kit Product Overview 43

NuQ-M H4K16(Ac) Cell Culture ELISA Kit 44

NuQ-M H4K16(Ac) Cell Culture ELISA Kit Product Overview 44

NuQ-M H4K20(Me)3 Cell Culture ELISA Kit 45

NuQ-M H4K20(Me)3 Cell Culture ELISA Kit Product Overview 45

NuQ-M H4Pan(Ac) Cell Culture ELISA Kit 46

NuQ-M H4Pan(Ac) Cell Culture ELISA Kit Product Overview 46

NuQ-M Ubiquityl H2A Cell Culture ELISA Kit 47

NuQ-M Ubiquityl H2A Cell Culture ELISA Kit Product Overview 47

NuQ-V 48

NuQ-V Product Overview 48

NuQ-V mH2A1.1 Cell Culture ELISA Kit 49

NuQ-V mH2A1.1 Cell Culture ELISA Kit Product Overview 49

NuQ-V mH2A2 Cell Culture ELISA Kit 50

NuQ-V mH2A2 Cell Culture ELISA Kit Product Overview 50

NuQ-X Hydroxymethylated DNA Cell Culture Kit 51

NuQ-X Hydroxymethylated DNA Cell Culture Kit Product Overview 51

NuQ-X Methylated DNA Cell Culture Kit 52

NuQ-X Methylated DNA Cell Culture Kit Product Overview 52

VolitionRX Ltd. - Key Competitors 53

VolitionRX Ltd. - Key Employees 54

VolitionRX Ltd. - Key Employee Biographies 55

VolitionRX Ltd. - Locations And Subsidiaries 56

Head Office 56

Other Locations & Subsidiaries 56

Recent Developments 57

VolitionRX Ltd., Recent Developments 57

Jun 24, 2016: VolitionRx Appoints Dr. Edward Futcher to Board of Directors 57

Jun 14, 2016: VolitionRx Publishes Study Confirming Stability of Circulating Cell-Free Nucleosomes as Biomarkers for Cancer Diagnostic Blood Tests 58

May 19, 2016: VolitionRx to Present Data Demonstrating Accuracy of NuQ Blood Test in Detecting Colorectal Cancer at World Endoscopy Organization (WEO) Meeting 59

May 13, 2016: VolitionRx Announces First Quarter 2016 Financial Results and Business Update 60

May 12, 2016: VolitionRx Initiates Clinical Trial with German Cancer Research Center (DKFZ) to Evaluate NuQ Blood Test for Pancreatic Cancer 62

Apr 20, 2016: VolitionRx Announces Study Results Showing NuQ Blood Test Detects Prostate Cancer Early with Significantly Higher Accuracy than PSA Test 63

Apr 14, 2016: VolitionRx Appoints Louise Day as Chief Marketing and Communications Officer 64

Apr 08, 2016: VolitionRx to Present at AACR Annual Meeting and Announce First Results from Prostate Cancer Study 65

Apr 07, 2016: VolitionRx Announces CE Mark for NuQ V001 for Detection of Colorectal Cancer 65

Apr 07, 2016: VolitionRx Announces CE Mark for NuQ T003 Blood Assay for Detection of Colorectal Cancer 67

Appendix 69

Methodology 69

About GlobalData 69

Contact Us 69

Disclaimer 69

List of Tables

List of Tables

VolitionRX Ltd. Pipeline Products and Clinical Trials Overview 9

VolitionRX Ltd. Pipeline Products by Equipment Type 9

VolitionRX Ltd. Pipeline Products by Indication 10

VolitionRX Ltd. Clinical Trials by Trial Status 10

VolitionRX Ltd., Key Facts 11

VolitionRX Ltd., Major Products and Services 12

VolitionRX Ltd. Number of Pipeline Products by Development Stage 13

VolitionRX Ltd. Pipeline Products Summary by Development Stage 14

VolitionRX Ltd. Clinical Trials by Trial Status 17

VolitionRX Ltd. Clinical Trials Summary 18

Colorectal Cancer Panel Test - Product Status 19

Colorectal Cancer Panel Test - Product Description 19

HyperGenomics Diagnostic Test - Colon Cancer - Product Status 20

HyperGenomics Diagnostic Test - Colon Cancer - Product Description 20

HyperGenomics Diagnostic Test - Leukaemia - Product Status 21

HyperGenomics Diagnostic Test - Leukaemia - Product Description 21

HyperGenomics Diagnostic Test - Prostate Cancer - Product Status 22

HyperGenomics Diagnostic Test - Prostate Cancer - Product Description 22

NuQ - A Androgen Receptor Cell Culture ELISA Kit - Product Status 23

NuQ - A Androgen Receptor Cell Culture ELISA Kit - Product Description 23

NuQ - A EZH2 Cell Culture ELISA Kit - Product Status 24

NuQ - A EZH2 Cell Culture ELISA Kit - Product Description 24

NuQ - A HMGB1 Cell Culture ELISA Kit - Product Status 25

NuQ - A HMGB1 Cell Culture ELISA Kit - Product Description 25

NuQ - A Oestrogen Receptor Cell Culture ELISA Kit - Product Status 26

NuQ - A Oestrogen Receptor Cell Culture ELISA Kit - Product Description 26

NuQ - A Progesterone Receptor Cell Culture ELISA Kit - Product Status 27

NuQ - A Progesterone Receptor Cell Culture ELISA Kit - Product Description 27

NuQ - Prostate Cancer - Product Status 28

NuQ - Prostate Cancer - Product Description 28

NuQ - Prostate Cancer - A Retrospective Study to Establish the Efficacy of VolitionRx's NuQ Test to Distinguish Anaplastic Prostate Cancer 29

NuQ - Prostate Cancer - Feasibility of VolitionRx's Proprietary NuQ Assays in Detecting Prostate Cancer 29

NuQ - T - Product Status 30

NuQ - T - Product Description 30

NuQ Diagnostic Test - Lung Cancer - Product Status 31

NuQ Diagnostic Test - Lung Cancer - Product Description 31

NuQ Diagnostic Test - Lung Cancer - Clinical Confirmatory Study Evaluatng the Accuracy of NuQ Test in Diagnosis of Subjects with Lung Cancer 32

NuQ Diagnostic Test - Lung Cancer - Detection of Lung Cancer with NuQ Blood Test 32

NuQ Diagnostic Test - Pancreatic Cancer - Product Status 33

NuQ Diagnostic Test - Pancreatic Cancer - Product Description 33

NuQ Diagnostic Test - Pancreatic Cancer - Clinical Trial with German Cancer Research Center (DKFZ) to Evaluate NuQ(R) Blood Test for Pancreatic Cancer 34

NuQ Endo - Product Status 35

NuQ Endo - Product Description 35

NuQ T003 Assay - Colorectal Cancer - Product Status 36

NuQ T003 Assay - Colorectal Cancer - Product Description 36

NuQ V001 Assay - Colorectal Cancer - Product Status 37

NuQ V001 Assay - Colorectal Cancer - Product Description 37

NuQ X001S Assay - Colorectal Cancer - Product Status 38

NuQ X001S Assay - Colorectal Cancer - Product Description 38

NuQ X001S Assay - Colorectal Cancer - Evaluate the Accuracy of NuQ Assays as an Initial Screening Tool for Detecting Colorectal Cancer: A Retrospective Study 39

NuQ X001S Assay - Colorectal Cancer - Extention of Sample Size for Analyzing the Effectiveness of NuQ Diagnostic Test in The Diagnosis of Colorectal Cancer: A Randomized Study 39

NuQ X001S Assay - Colorectal Cancer - Study to Target NuQ Biomarker Panel for Colorectal Polyps 39

NuQ-B - Product Status 40

NuQ-B - Product Description 40

NuQ-IHC - Product Status 41

NuQ-IHC - Product Description 41

NuQ-M Gamma - H2AX Cell Culture ELISA Kit - Product Status 42

NuQ-M Gamma - H2AX Cell Culture ELISA Kit - Product Description 42

NuQ-M H3K27(Me)3 Cell Culture ELISA Kit - Product Status 43

NuQ-M H3K27(Me)3 Cell Culture ELISA Kit - Product Description 43

NuQ-M H4K16(Ac) Cell Culture ELISA Kit - Product Status 44

NuQ-M H4K16(Ac) Cell Culture ELISA Kit - Product Description 44

NuQ-M H4K20(Me)3 Cell Culture ELISA Kit - Product Status 45

NuQ-M H4K20(Me)3 Cell Culture ELISA Kit - Product Description 45

NuQ-M H4Pan(Ac) Cell Culture ELISA Kit - Product Status 46

NuQ-M H4Pan(Ac) Cell Culture ELISA Kit - Product Description 46

NuQ-M Ubiquityl H2A Cell Culture ELISA Kit - Product Status 47

NuQ-M Ubiquityl H2A Cell Culture ELISA Kit - Product Description 47

NuQ-V - Product Status 48

NuQ-V - Product Description 48

NuQ-V mH2A1.1 Cell Culture ELISA Kit - Product Status 49

NuQ-V mH2A1.1 Cell Culture ELISA Kit - Product Description 49

NuQ-V mH2A2 Cell Culture ELISA Kit - Product Status 50

NuQ-V mH2A2 Cell Culture ELISA Kit - Product Description 50

NuQ-X Hydroxymethylated DNA Cell Culture Kit - Product Status 51

NuQ-X Hydroxymethylated DNA Cell Culture Kit - Product Description 51

NuQ-X Methylated DNA Cell Culture Kit - Product Status 52

NuQ-X Methylated DNA Cell Culture Kit - Product Description 52

VolitionRX Ltd., Key Employees 54

VolitionRX Ltd., Key Employee Biographies 55

VolitionRX Ltd., Subsidiaries 56

List of Figures

List of Figures

VolitionRX Ltd. Pipeline Products by Equipment Type 10

VolitionRX Ltd. Pipeline Products by Development Stage 13

VolitionRX Ltd. Clinical Trials by Trial Status 17

Save time and money with a subscription

Require regular access to company intelligence? Why not consider a cost-effective subscription platform and gain access to 250,000+ reports?

To find out more, click here or call +91 (0)40 4961 4567.

Single User License
Electronic PDF copy delivered via email.

Report can be used by individual purchaser only.

$750

Site License
Electronic PDF copy delivered via email.

Report can be shared by unlimited users within one corporate location,
e.g. a regional office.

$1500

Global License
Electronic PDF copy delivered via email.

Report can be shared globally by unlimited users within the purchasing corporation
e.g. all employees of a single company.

$2250

TOP